Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
When initiating or up-titrating Rybelsus in patients also taking insulin or sulfonylureas, consider reducing the doses of these medications to minimise the risk of hypoglycaemia
Published Dec
Should I stop Mounjaro if I'm planning to become pregnant
Digestive benefits like reduced bloating and improved regularity also receive frequent praise
KFF polling found about half of adults in the U.S